The compound has not been subjected to the demanding scientific testing essential for approval by regulatory bodies like the FDA, which suggests its basic safety and success in treating medical ailments continue being unproven.When evaluating conolidine with regular analgesics, discrepancies in protection profiles and Unwanted effects occur. Regula